Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Aligos Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +7 vs. Q4 2022
- Shares held
- 27.3M
- +787.4K (+3.0%) vs. Q4 2022
- Total value
- $23.9M
- −$1.35M (−5.4%) vs. Q4 2022
- New holders
- 10
- 13 more added
- Sold out
- 3
- 11 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.2M |
| Q1 2026 | 35 | $20.6M |
| Q4 2025 | 41 | $26.2M |
| Q3 2025 | 33 | $26.0M |
| Q2 2025 | 37 | $19.5M |
| Q1 2025 | 35 | $27.1M |
| Q4 2024 | 34 | $64.5M |
| Q3 2024 | 27 | $14.7M |
| Q2 2024 | 49 | $16.6M |
| Q1 2024 | 49 | $45.3M |
| Q4 2023 | 40 | $30.1M |
| Q3 2023 | 36 | $19.2M |
| Q2 2023 | 41 | $25.5M |
| Q1 2023 | 46 | $23.9M |
| Q4 2022 | 39 | $25.3M |
| Q3 2022 | 52 | $30.4M |
| Q2 2022 | 60 | $36.0M |
| Q1 2022 | 76 | $68.4M |
| Q4 2021 | 71 | $390.4M |
| Q3 2021 | 68 | $483.9M |
| Q2 2021 | 58 | $550.5M |
| Q1 2021 | 52 | $612.4M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Aligos Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 92 | $0 | 0.00% | +92 | New |
| Newbridge Financial Services Group, Inc. | 37 | $32 | 0.00% | 00.0% | Unchanged |
| ZRC Wealth Management, LLC | 100 | $88 | 0.00% | +100 | New |
| Wells Fargo & Company | 176 | $154 | 0.00% | +3+1.7% | Added |
| Point72 Asset Management, L.P. | 247 | $216 | 0.00% | −905,649−100.0% | Reduced |
| FMR LLC | 1,000 | $874 | 0.00% | −12−1.2% | Reduced |
| JPMorgan Chase & Co | 677 | $1.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,579 | $1.00K | 0.00% | +1,579 | New |
| Federated Hermes, Inc. | 1,623 | $1.42K | 0.00% | −1,557−49.0% | Reduced |
| UBS Group AG | 2,329 | $2.04K | 0.00% | +2,329 | New |
| Advisor Group Holdings, Inc. | 8,000 | $6.99K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 13,292 | $11.6K | 0.00% | +13,289+442,966.7% | Added |
| CWM, LLC | 16,891 | $15.0K | 0.00% | +16,891 | New |
| HarbourVest Partners LLC | 18,783 | $16.4K | 0.01% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 24,594 | $21.5K | 0.00% | +24,594 | New |
| HRT Financial LP | 26,273 | $22.0K | 0.00% | −39,986−60.3% | Reduced |
| Jane Street Group, LLC | 26,249 | $22.9K | 0.00% | +9,829+59.9% | Added |
| Northern Trust Corp | 39,351 | $34.4K | 0.00% | +6,747+20.7% | Added |
| Royal Bank of Canada | 44,715 | $39.0K | 0.00% | +44,697+248,316.7% | Added |
| Man Group plc | – | $49.5K | 0.00% | – | New |
| Two Sigma Investments, LP | 56,857 | $49.7K | 0.00% | −33,561−37.1% | Reduced |
| Deutsche Bank AG | 71,290 | $62.3K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 78,200 | $68.3K | 0.00% | −4,300−5.2% | Reduced |
| Citadel Advisors LLC | 87,877 | $76.8K | 0.00% | +1,599+1.9% | Added |
| Bridgeway Capital Management, LLC | 92,000 | $80.4K | 0.00% | −20,000−17.9% | Reduced |
| State Street Corp | 97,423 | $85.1K | 0.00% | +36,600+60.2% | Added |
| Marshall Wace, LLP | 108,588 | $94.5K | 0.00% | +108,588 | New |
| Morgan Stanley | 132,724 | $116.0K | 0.00% | +130,371+5,540.6% | Added |
| Geode Capital Management, LLC | 199,858 | $174.7K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 307,601 | $268.8K | 0.00% | +1520.0% | Added |
| Millennium Management LLC | 403,370 | $353.0K | 0.00% | +32,051+8.6% | Added |
| Renaissance Technologies LLC | 452,860 | $396.0K | 0.00% | −79,400−14.9% | Reduced |
| Acadian Asset Management LLC | 564,715 | $492.0K | 0.00% | +230,011+68.7% | Added |
| Silverarc Capital Management, LLC | 631,887 | $552.3K | 0.25% | +631,887 | New |
| Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $649.6K | 0.27% | 00.0% | Unchanged |
| Logos Global Management LP | 1,000,000 | $874.0K | 0.13% | +1,000,000 | New |
| Vanguard Group Inc | 1,016,681 | $888.6K | 0.00% | +3,185+0.3% | Added |
| Newtyn Management, LLC | 1,021,461 | $892.8K | 0.18% | −478,539−31.9% | Reduced |
| Bank of America Corp | 1,147,783 | $1.00M | 0.00% | −2,365−0.2% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,223,278 | $1.07M | 0.00% | −250,000−17.0% | Reduced |
| Baker Bros. Advisors LP | 2,076,400 | $1.81M | 0.01% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 2,309,764 | $2.02M | 0.04% | 00.0% | Unchanged |
| Versant Venture Management, LLC | 2,320,381 | $2.03M | 4.23% | 00.0% | Unchanged |
| Tang Capital Management LLC | 3,424,800 | $2.99M | 0.45% | +608,409+21.6% | Added |
| Vivo Capital, LLC | 3,547,030 | $3.10M | 0.23% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 3,948,360 | $3.45M | 0.11% | 00.0% | Unchanged |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −263,832−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −36,367−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −85−100.0% | Sold out |